OpenLegislation

Paragraph 5 Marketing authorizations

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Where a marketing authorization relates to any two or more of the kinds of medicinal product described in entries 2(b), (c) or (d) of the Table in paragraph 1, the fee payable under regulation 14(3) shall be in accordance with the lower of the fees specified as corresponding to those entries in Column 2 of that Table.